查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1709463

非侵入性幽門螺旋桿菌檢測市場，按檢測類型、按技術、按分佈、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Non-invasive Helicobacter Pylori Testing Market, By Test Type, By Technology, By Distribution, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 298 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年非侵入性幽門螺旋桿菌檢測市場規模價值 2.9733 億美元，2025 年至 2032 年的複合年成長率為 7.50%。

非侵入性幽門螺旋桿菌檢測市場-市場動態

為了方便起見，家庭使用幽門螺旋桿菌檢測試劑盒的需求不斷增加。

對家用幽門螺旋桿菌檢測試劑盒的需求不斷成長，這是非侵入性幽門螺旋桿菌檢測市場的主要驅動力。消費者喜歡方便的、在家中就能進行的診斷解決方案，無需前往診所就診。這些試劑盒具有隱私性、易用性和快速結果等特點，對於早期檢測很有吸引力。遠距醫療和數位醫療平台的興起進一步支持了它們的採用，允許根據測試結果進行遠端諮詢。此外，人們對胃病和預防性醫療保健的認知不斷提高也推動了市場的成長。快速抗原和呼氣測試技術的進步提高了家庭測試的準確性和可靠性。自我檢測解決方案的監管批准正在擴大其可近性，特別是在醫療保健基礎設施有限的地區。電子商務的不斷普及也促進了銷售，使得這些套件廣泛普及。隨著醫療保健向個人化和預防性醫療轉變，家庭幽門螺旋桿菌檢測預計將會出現強烈的需求。

非侵入性幽門螺旋桿菌檢測市場－關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 7.50%。

根據測試類型細分，預計尿素呼氣試驗 (UBT) 將在 2024 年佔據最大市場佔有率

根據技術細分，分子診斷是 2024 年的領先技術

根據分銷細分，醫院藥局是 2024 年的主要分銷管道

根據最終用戶細分，醫院和診所是 2024 年領先的最終用戶

按地區分類，亞太地區是 2024 年最大的收入來源

非侵入性幽門螺旋桿菌檢測市場-細分分析：

全球非侵入性幽門螺旋桿菌檢測市場根據檢測類型、技術、分佈、最終用戶和地區進行細分。

根據測試類型，市場分為三類：尿素呼氣測試（UBT）、糞便抗原測試（SAT）、血液抗體測試。尿素呼氣試驗 (UBT) 因其在檢測活動性感染方面的高準確性、易用性和可靠性而在非侵入性幽門螺旋桿菌檢測市場佔據主導地位。與無法區分過去感染和現在感染的血液抗體測試不同，UBT 可直接測量尿素酶活性，這是幽門螺旋桿菌存在的關鍵標誌。由於其非侵入性和快速的結果，它在醫院、診斷實驗室和家庭環境中受到廣泛青睞。

醫療保健專業人士青睞 UBT，因為它可以提供即時感染狀況，使其成為治療監測和根除確認的黃金標準。該測試也得到了全球衛生組織的認可，進一步提高了其採用率。技術進步帶來了攜帶式和易於使用的呼吸測試設備，提高了可及性。此外，胃病患病率的上升和政府支持的篩檢計畫也支持了市場的成長。隨著對高效且患者友好的診斷方法的需求不斷增加，UBT 仍然是最廣泛使用的非侵入性幽門螺旋桿菌測試。

根據技術，市場分為三類：分子診斷、基於免疫測定的測試、色譜技術。分子診斷技術憑藉其高靈敏度、特異性和檢測低細菌負荷的能力，在非侵入性幽門螺旋桿菌檢測市場中佔據主導地位。與傳統方法不同，分子診斷，特別是基於聚合酶鍊式反應 (PCR) 的測試，可以直接識別幽門螺旋桿菌 DNA，即使在無症狀患者中也能確保準確的結果。這使得它成為臨床實驗室和研究環境的首選。

即時 PCR (qPCR) 和次世代定序 (NGS) 的日益普及進一步提高了診斷的精確度。分子測試可以快速提供結果，減少重複測試的需要並能夠及時做出治療決定。此外，這些技術還可以檢測抗生素抗藥性，有助於指導有效的治療策略。政府和醫療保健組織正在推廣先進的診斷技術以改善胃病管理，從而推動需求。隨著診斷和即時分子檢測自動化的不斷發展，分子診斷仍然是該市場的領先技術。

非侵入性幽門螺旋桿菌檢測市場-地理洞察

由於幽門螺旋桿菌感染率高以及人們對胃腸道疾病的認知不斷提高，亞太地區非侵入性幽門螺旋桿菌檢測市場正在擴大。中國、印度和日本等國家面臨嚴重的幽門螺旋桿菌相關疾病負擔，因此對早期和準確的診斷的需求很大。尿素呼氣試驗 (UBT) 和糞便抗原測試 (SAT) 由於其可靠性和非侵入性而越來越受到人們的歡迎。政府推動的胃癌篩檢計劃進一步支持了市場成長。該地區不斷擴大的醫療保健基礎設施、不斷增加的可支配收入以及日益成長的醫療旅遊業提高了獲得先進診斷方法的可及性。此外，透過電子商務平台提供的家用檢測試劑盒越來越多，這也推動了市場滲透。技術進步和創新診斷解決方案的監管批准繼續塑造市場格局。

由於中國幽門螺旋桿菌感染率高，影響到近50%的人口，因此中國非侵入性幽門螺旋桿菌檢測市場正經歷強勁成長。人們對胃病、潰瘍和胃癌風險的認知不斷提高，推動了對早期和非侵入性診斷方法的需求。中國政府一直在推動胃癌篩檢計劃，進一步加速市場擴張。

尿素呼氣試驗（UBT）因其準確度高、方便性等特點，是中國應用最廣泛的檢測方法。糞便抗原測試（SAT）的採用也正在成長，特別是在醫院和診斷實驗室。同時，隨著電子商務平台和遠距醫療服務的興起，家庭幽門螺旋桿菌檢測試劑盒的供應量正在增加。由於方便、實惠且可減少醫院就診次數，消費者更喜歡在家中進行診斷。

非侵入性幽門螺旋桿菌檢測市場-競爭格局：

非侵入性幽門螺旋桿菌檢測市場競爭激烈，各公司都專注於技術進步、產品創新和策略合作，以擴大市場佔有率。賽默飛世爾科技、雅培和 DiaSorin 等領先公司在分子診斷、免疫測定試劑盒和尿素呼氣測試領域佔據主導地位。不斷增加的研發投入正在提高測試的準確性，而診斷實驗室的自動化正在提高效率。

家庭檢測試劑盒和數位醫療解決方案的興起進一步加劇了競爭。公司也在擴大其全球分銷網路，尤其是在新興市場。監管部門的批准和政府支持的篩選計劃繼續影響市場動態。

最新動態：

2023 年 7 月，Meridian Bioscience 的最新幽門螺旋桿菌診斷測試 Premier HpSA Flex 獲得 FDA 批准，標誌著非侵入性測試取得了重大進展。這項發展鞏固了該公司在非侵入性幽門螺旋桿菌檢測市場的地位，並增強了其診斷產品。

目錄

第1章：非侵入性幽門螺旋桿菌檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 非侵入性幽門螺旋桿菌檢測市場片段（依檢測類型）
    • 非侵入性幽門螺旋桿菌檢測市場（按技術）
    • 非侵入性幽門螺旋桿菌檢測市場片段（按配銷通路）
    • 非侵入性幽門螺旋桿菌檢測市場片段（按最終用戶）
    • 非侵入性幽門螺旋桿菌檢測市場（按國家/地區）
    • 非侵入性幽門螺旋桿菌檢測市場（按地區）
  • 競爭洞察

第3章：非侵入性幽門螺旋桿菌檢測主要市場趨勢

  • 非侵入性幽門螺旋桿菌檢測市場促進因素
    • 市場促進因素的影響分析
  • 非侵入性幽門螺旋桿菌檢測市場限制
    • 市場限制的影響分析
  • 非侵入性幽門螺旋桿菌檢測市場機會
  • 非侵入性幽門螺旋桿菌檢測市場未來趨勢

第4章：非侵入性幽門螺旋桿菌檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：非侵入性幽門螺旋桿菌檢測市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：非侵入性幽門螺旋桿菌檢測市場格局

  • 2024年非侵入性幽門螺旋桿菌檢測市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：非侵入性幽門螺旋桿菌檢測市場 - 按檢測類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 尿素呼氣試驗（UBT）
    • 糞便抗原檢測（SAT）
    • 血液抗體檢測

第 8 章：非侵入性幽門螺旋桿菌檢測市場 - 依技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 分子診斷
    • 基於免疫測定的檢測
    • 色譜技術

第9章：非侵入性幽門螺旋桿菌檢測市場－按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 機器翻譯整合
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第 10 章：非侵入性幽門螺旋桿菌檢測市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和診所
    • 診斷實驗室
    • 居家照護環境

第 11 章：非侵入性幽門螺旋桿菌檢測市場-按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美非侵入性幽門螺旋桿菌檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模及預測（按配銷通路）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲非侵入性幽門螺旋桿菌檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（按配銷通路）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區非侵入性幽門螺旋桿菌檢測主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（按配銷通路）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲非侵入性幽門螺旋桿菌檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（按配銷通路）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲非侵入性幽門螺旋桿菌檢測主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依測試類型）
    • MEA 市場規模及預測（依技術）
    • MEA 市場規模及預測（依配銷通路）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：主要供應商分析-非侵入性幽門螺旋桿菌檢測產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • DiaSorin SpA
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • QuidelOrtho Corporation
    • Meridian Bioscience, Inc.
    • Coris BioConcept
    • Sekisui Diagnostics
    • Alfa Scientific Designs, Inc.
    • Halyard Health, Inc.
    • Kibion AB
    • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • CerTest Biotec SL
    • BIOHIT HealthCare Ltd.
    • Medline Industries, LP
    • Cardinal Health, Inc.
    • Luminex Corporation

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4933

REPORT HIGHLIGHT

Non-invasive Helicobacter Pylori Testing Market size was valued at US$ 297.33 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.

The non-invasive Helicobacter pylori (H. pylori) testing market focuses on diagnostic methods that detect infections without requiring endoscopic procedures. These tests include urea breath tests (UBT), stool antigen tests (SAT), and blood antibody tests. UBT is highly accurate, detecting urease enzyme activity, while SAT identifies bacterial antigens in stool samples. Blood tests check for antibodies but are less reliable for active infections. The market is driven by the high prevalence of H. pylori, linked to ulcers and gastric cancer, and the increasing preference for non-invasive diagnostics. Growing awareness, improved healthcare access, and advancements in point-of-care testing further boost demand. North America, Europe, and Asia-Pacific lead the market due to well-established healthcare systems and rising gastrointestinal disease cases. Regulatory approvals and innovations in diagnostic technology continue to shape market expansion.

Non-invasive Helicobacter Pylori Testing Market- Market Dynamics

Rising demand for home-based H. pylori testing kits for convenience.

The growing demand for home-based H. pylori testing kits is a key driver in the non-invasive H. pylori testing market. Consumers prefer convenient, at-home diagnostic solutions that eliminate the need for clinical visits. These kits offer privacy, ease of use, and quick results, making them attractive for early detection. The rise of telemedicine and digital healthcare platforms further supports their adoption, allowing remote consultations based on test results. Additionally, increasing awareness about gastric diseases and preventive healthcare fuels market growth. Advancements in rapid antigen and breath test technologies enhance the accuracy and reliability of at-home testing. Regulatory approvals for self-testing solutions are expanding accessibility, especially in regions with limited healthcare infrastructure. Growing e-commerce penetration also boosts sales, making these kits widely available. As healthcare shifts toward personalized and preventive medicine, home-based H. pylori tests are expected to see strong demand.

Non-invasive Helicobacter Pylori Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.50% over the forecast period (2025-2032)

Based on Test Type segmentation, Urea Breath Test (UBT) was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Molecular Diagnostics was the leading Technology in 2024

Based on distribution segmentation, Hospital-Based Pharmacies was the leading distribution in 2024

Based on End-user segmentation, Hospitals & Clinics was the leading End-user in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

Non-invasive Helicobacter Pylori Testing Market- Segmentation Analysis:

The Global Non-invasive Helicobacter Pylori Testing Market is segmented on the basis of Test Type, Technology, Distribution, end-user, and Region.

The market is divided into three categories based on Test Type: Urea Breath Test (UBT), Stool Antigen Test (SAT), Blood Antibody Test. The Urea Breath Test (UBT) dominates the non-invasive H. pylori testing market due to its high accuracy, ease of use, and reliability in detecting active infections. Unlike blood antibody tests, which cannot distinguish between past and present infections, UBT directly measures urease enzyme activity, a key marker of H. pylori presence. It is widely preferred in hospitals, diagnostic labs, and home-based settings due to its non-invasive nature and quick results.

Healthcare professionals favor UBT because it provides real-time infection status, making it the gold standard for treatment monitoring and eradication confirmation. The test is also endorsed by global health organizations, further increasing adoption. Technological advancements have led to portable and easy-to-use breath test devices, enhancing accessibility. Additionally, the rising prevalence of gastric diseases and government-backed screening programs support market growth. With increasing demand for efficient and patient-friendly diagnostics, UBT remains the most widely used non-invasive H. pylori test.

The market is divided into three categories based on Technology: Molecular Diagnostics, Immunoassay-Based Testing, Chromatographic Techniques. Molecular Diagnostics dominates the non-invasive H. pylori testing market due to its high sensitivity, specificity, and ability to detect low bacterial loads. Unlike traditional methods, molecular diagnostics, particularly Polymerase Chain Reaction (PCR)-based tests, identify H. pylori DNA directly, ensuring accurate results even in asymptomatic patients. This makes it a preferred choice in clinical laboratories and research settings.

The increasing adoption of real-time PCR (qPCR) and next-generation sequencing (NGS) has further improved diagnostic precision. Molecular tests provide rapid results, reducing the need for repeated testing and enabling timely treatment decisions. Moreover, these technologies allow for antibiotic resistance detection, helping guide effective treatment strategies. Governments and healthcare organizations are promoting advanced diagnostic techniques to improve gastric disease management, driving demand. As automation in diagnostics and point-of-care molecular tests continue to advance, molecular diagnostics remains the leading technology in this market.

Non-invasive Helicobacter Pylori Testing Market- Geographical Insights

The Asia-Pacific non-invasive H. pylori testing market is expanding due to the high prevalence of H. pylori infections and increasing awareness of gastrointestinal diseases. Countries like China, India, and Japan have a significant burden of H. pylori-related conditions, driving the demand for early and accurate diagnostics. The adoption of urea breath tests (UBT) and stool antigen tests (SAT) is rising due to their reliability and non-invasive nature. Government initiatives promoting gastric cancer screening programs further support market growth. The expanding healthcare infrastructure, rising disposable income, and growing medical tourism in the region enhance accessibility to advanced diagnostics. Additionally, the increasing availability of home-based testing kits through e-commerce platforms is fueling market penetration. Technological advancements and regulatory approvals for innovative diagnostic solutions continue to shape the market landscape.

The non-invasive H. pylori testing market in China is witnessing strong growth due to the high prevalence of H. pylori infections, affecting nearly 50% of the population. The increasing awareness about gastric diseases, ulcers, and gastric cancer risks is driving the demand for early and non-invasive diagnostic methods. The Chinese government has been promoting gastric cancer screening programs, further accelerating market expansion.

Urea breath tests (UBT) are the most widely used method in China due to their high accuracy and convenience. The adoption of stool antigen tests (SAT) is also growing, particularly in hospitals and diagnostic laboratories. Meanwhile, the availability of home-based H. pylori testing kits is increasing, driven by the rise of e-commerce platforms and telemedicine services. Consumers prefer at-home diagnostics due to convenience, affordability, and reduced hospital visits.

Non-invasive Helicobacter Pylori Testing Market- Competitive Landscape:

The non-invasive H. pylori testing market is highly competitive, with companies focusing on technological advancements, product innovation, and strategic collaborations to expand their market share. Leading players such as Thermo Fisher Scientific, Abbott, and DiaSorin dominate with molecular diagnostics, immunoassay-based kits, and urea breath tests. Increasing R&D investments are enhancing test accuracy, while automation in diagnostic labs is improving efficiency.

The rise of home-based testing kits and digital healthcare solutions is further intensifying competition. Companies are also expanding their global distribution networks, especially in emerging markets. Regulatory approvals and government-backed screening programs continue to influence market dynamics.

Recent Developments:

In July 2023, Meridian Bioscience secured FDA clearance for its latest H. pylori diagnostic test, Premier HpSA Flex, marking a significant advancement in non-invasive testing. This development strengthened the company's position in the non-invasive H. pylori testing market and enhanced its diagnostic offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • Meridian Bioscience, Inc.
  • Coris BioConcept
  • Sekisui Diagnostics
  • Alfa Scientific Designs, Inc.
  • Halyard Health, Inc.
  • Kibion AB
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • CerTest Biotec S.L.
  • BIOHIT HealthCare Ltd.
  • Medline Industries, LP
  • Cardinal Health, Inc.
  • Luminex Corporation

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urea Breath Test (UBT)
  • Stool Antigen Test (SAT)
  • Blood Antibody Test

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassay-Based Testing
  • Chromatographic Techniques

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY DISTRIBUTION- CHANNEL MARKET ANALYSIS, 2019 - 2032

  • Machine Translation Integration
  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-invasive Helicobacter Pylori Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-invasive Helicobacter Pylori Testing Market Snippet by Test Type
    • 2.1.2. Non-invasive Helicobacter Pylori Testing Market Snippet by Technology
    • 2.1.3. Non-invasive Helicobacter Pylori Testing Market Snippet by Distribution Channel
    • 2.1.4. Non-invasive Helicobacter Pylori Testing Market Snippet by End-user
    • 2.1.5. Non-invasive Helicobacter Pylori Testing Market Snippet by Country
    • 2.1.6. Non-invasive Helicobacter Pylori Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-invasive Helicobacter Pylori Testing Key Market Trends

  • 3.1. Non-invasive Helicobacter Pylori Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-invasive Helicobacter Pylori Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-invasive Helicobacter Pylori Testing Market Opportunities
  • 3.4. Non-invasive Helicobacter Pylori Testing Market Future Trends

4. Non-invasive Helicobacter Pylori Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-invasive Helicobacter Pylori Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Non-invasive Helicobacter Pylori Testing Market Landscape

  • 6.1. Non-invasive Helicobacter Pylori Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-invasive Helicobacter Pylori Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Urea Breath Test (UBT)
    • 7.1.3. Stool Antigen Test (SAT)
    • 7.1.4. Blood Antibody Test

8. Non-invasive Helicobacter Pylori Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Immunoassay-Based Testing
    • 8.1.4. Chromatographic Techniques

9. Non-invasive Helicobacter Pylori Testing Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Machine Translation Integration
    • 9.1.3. Hospital-Based Pharmacies
    • 9.1.4. Retail Pharmacies
    • 9.1.5. Online Pharmacies

10. Non-invasive Helicobacter Pylori Testing Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Home Care Settings

11. Non-invasive Helicobacter Pylori Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Helicobacter Pylori Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. DiaSorin S.p.A.
    • 12.2.3. Abbott Laboratories
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. QuidelOrtho Corporation
    • 12.2.6. Meridian Bioscience, Inc.
    • 12.2.7. Coris BioConcept
    • 12.2.8. Sekisui Diagnostics
    • 12.2.9. Alfa Scientific Designs, Inc.
    • 12.2.10. Halyard Health, Inc.
    • 12.2.11. Kibion AB
    • 12.2.12. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • 12.2.13. CerTest Biotec S.L.
    • 12.2.14. BIOHIT HealthCare Ltd.
    • 12.2.15. Medline Industries, LP
    • 12.2.16. Cardinal Health, Inc.
    • 12.2.17. Luminex Corporation

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us